These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37422261)

  • 1. Abdominal Castleman's disease with 18F-FDG PET/CT.
    Badenes Romero Á; Milà López M; Vallansot RO; Achury Murcia CA; Patricia Fierro Alanis M; Carrera Salazar D; Muro VI; Quintero Caicedo LM
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(6):418-419. PubMed ID: 37422261
    [No Abstract]   [Full Text] [Related]  

  • 2. Unicentric Castleman's Disease Revealed by 18F-FDG PET/CT and Somatostatin Receptor Scintigraphy With 99mTc-HYNIC-TOC.
    Luo Y; Wang L; Pan Q; Ma Y; Li F
    Clin Nucl Med; 2018 Jul; 43(7):551-552. PubMed ID: 29742598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET/CT in the follow up of recurrence with histopathologic confirmation.
    Iagaru A; Mari C; Sam Gambhir S
    Rev Esp Med Nucl; 2007; 26(1):40-5. PubMed ID: 17286947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Castleman's Disease of the Kidney Mimicking Renal Cell Carcinoma on FDG PET/CT.
    Wang Y; Dong A; Yang B; Lu J
    Clin Nucl Med; 2018 May; 43(5):e160-e163. PubMed ID: 29432340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary experience of 18F-fluorodeoxyglucose positron emission tomography in Castleman's disease.
    Robinson H; Prince HM; Ramdave S; Seymour JF; Elliott P; Hicks R
    Leuk Lymphoma; 2006 Dec; 47(12):2664-6. PubMed ID: 17169817
    [No Abstract]   [Full Text] [Related]  

  • 6. PET/CT imaging with 18F-FDG in Castleman disease.
    Delgado A; Mesa J; Guayambuco S; Rodriguez T; Fernández I; Rodeño E
    Rev Esp Med Nucl Imagen Mol; 2016; 35(3):200-1. PubMed ID: 26614744
    [No Abstract]   [Full Text] [Related]  

  • 7. 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in a patient with human immunodeficiency virus-associated Castleman's disease and Kaposi sarcoma, disorders associated with human herpes virus 8 infection.
    Bertagna F; Biasiotto G; Rodella R; Giubbini R; Alavi A
    Jpn J Radiol; 2010 Apr; 28(3):231-4. PubMed ID: 20437136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of primary hepatic myopericytoma and mediastinal Castleman disease in one patient: an interesting 18F-FDG PET/CT imaging case.
    Ma GY; Guan ZW
    Chin Med J (Engl); 2021 Sep; 134(20):2498-2499. PubMed ID: 34561326
    [No Abstract]   [Full Text] [Related]  

  • 9. FDG positron emission tomographic scintigraphy can reveal Castleman's disease as a cause of inflammation.
    Blockmans D; Maes A; Stroobants S; Bobbaers H; Mortelmans L
    Clin Nucl Med; 2001 Nov; 26(11):975-6. PubMed ID: 11595872
    [No Abstract]   [Full Text] [Related]  

  • 10. Paraneoplastic Pemphigus Associated With Castleman Disease Detected by 18F-FDG PET/CT.
    Fu Z; Liu M; Chen X; Yang X; Li Q
    Clin Nucl Med; 2018 Jun; 43(6):464-465. PubMed ID: 29561527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Castleman's disease presenting as fever of unknown origin: diagnostic value of fluorodeoxyglucose-positron emission tomography/computed tomography.
    Roca B; Torres V
    Am J Med Sci; 2009 Apr; 337(4):295-6. PubMed ID: 19402208
    [No Abstract]   [Full Text] [Related]  

  • 12. F-18 fluorodeoxyglucose positron emission tomography in mesenterial Castleman's lymphoma.
    Kunishima S; Taniguchi H; Koh T; Yamaguchi A; Yamagishi H
    Clin Nucl Med; 2001 Sep; 26(9):789-90. PubMed ID: 11507303
    [No Abstract]   [Full Text] [Related]  

  • 13. FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease.
    Barker R; Kazmi F; Stebbing J; Ngan S; Chinn R; Nelson M; O'Doherty M; Bower M
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):648-52. PubMed ID: 19050873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Castleman's disease. Large retroperitoneal masses and multiple calcifications detected by
    Xiao L; Zhu HM; Li L
    Hell J Nucl Med; 2019; 22(3):220-221. PubMed ID: 31587031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonic Castleman Disease on FDG PET/CT.
    Li F; Xiao L; Cai H; Li L
    Clin Nucl Med; 2023 Jan; 48(1):71-72. PubMed ID: 35961369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A huge retroperitoneal Castleman's disease - rare entity.
    Jaishanker S; D'Cruze L; Muralidharan S; Gunabooshanam B; Singh KB
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S980-S982. PubMed ID: 38384096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Mixed Variant of Castleman Disease Detected by Somatostatin Receptor Scintigraphy with 99mTc-HYNIC-TOC and 18F-FDG PET/CT.
    Pan Q; Zhang X; Luo Y; Ma Y; Li F
    Clin Nucl Med; 2019 Feb; 44(2):164-166. PubMed ID: 30516666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare case of Castleman disease mimicking a pancreatic tumor.
    Gülmez S; Keklikkıran ZZ; Ölmez T; Barışık NÖ
    Ann Ital Chir; 2019 Dec; 8():. PubMed ID: 31894755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 68Ga-DOTATATE and 18F-FDG in Castleman Disease.
    Verçosa AFA; Flamini MEDM; Loureiro LVM; Flamini RC
    Clin Nucl Med; 2020 Nov; 45(11):868-870. PubMed ID: 32969902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW; Nam SB; Kim SJ
    Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.